Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Cross-cultural adaptation of the PROFFIT Instrument to measure financial toxicity in people living with cancer within a UK population.
Journal: Journal of cancer policy
Published: June 07, 2023
NET-02: a randomised, non-comparative, phase II trial of nal-IRI/5-FU or docetaxel as second-line therapy in patients with progressive poorly differentiated extra-pulmonary neuroendocrine carcinoma.
Journal: EClinicalMedicine
Published: March 27, 2023
A Phase Ib Study of NUC-1031 in Combination with Cisplatin for the First-Line Treatment of Patients with Advanced Biliary Tract Cancer (ABC-08).
Journal: The oncologist
Published: July 01, 2020
An evaluation of cetuximab dosing strategies using pharmacokinetics and cost analysis.
Journal: The Journal of pharmacy and pharmacology
Published: September 27, 2018
Dose Rationalization of Pembrolizumab and Nivolumab Using Pharmacokinetic Modeling and Simulation and Cost Analysis.
Journal: Clinical pharmacology and therapeutics
Published: June 23, 2017
Showing 1-5 of 5
Last Updated: 09/26/2026